Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-2626

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-2626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Divalproex Sodium 500mg 70518 2626 01)

Mm2 (Divalproex Sodium  500mg 70518 2626 01)
Label for Divalproex Sodium 500 mg delayed-release tablet, quantity 1, repackaged by RemedyRepack Inc. The label includes NDC 70518-2626-01, manufacturer Unichem Pharma Inc., storage directions, and a QR code.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Divalproex Sodium 500 mg delayed-release oral tablets. The package contains 100 tablets. The label shows the NDC number 70518-2626-00 and states the product is repackaged by RemedyRepack Inc. Directions refer users to the package insert. Storage instructions specify 20-25°C with allowable excursions. Manufacturer is Unichem Pharma Inc., Hasbrouck Heights, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.